Organigram Product Development Collaboration Completes Landmark Clinical Study on Nanoemulsion Technology

 Organigram Product Development Collaboration Completes Landmark Clinical Study on Nanoemulsion Technology

FAST Nanoemulsion Technology Expected to be a Competitive Advantage for Organigrams Ingestible Portfolio
TORONTO Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), a leading licensed producer of can…